Acneiform eruption in a patient receiving bevacizumab for glioblastoma multiforme

Archives of Dermatology

Volumn 146, Issue 5, 2010, Pages 577-

  Keenan, Bridget P ^a   Abuav, Rachel ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; RITUXIMAB;

ACNE; ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; GLIOBLASTOMA; HUMAN; MALE; PRIORITY JOURNAL; RASH;

ACNEIFORM ERUPTIONS; ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; DRUG ERUPTIONS; GLIOBLASTOMA; HUMANS; MALE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77952650239     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.68     Document Type: Article

References (5)

1. Saif MW, Longo WL, Israel G. Correlation between rash and a positive drug response associated with bevacizumab in a patient with advanced colorectal cancer. Clin Colorectal Cancer. 2008;7(2):144-148. (Pubitemid 351518777)
2. Gotlib V, Khaled S, Lapko I, Mar N, Saif MW. Skin rash secondary to bevacizumab in a patient with advanced colorectal cancer and relation to response. Anticancer Drugs. 2006;17(10):1227-1229. (Pubitemid 44673405)
3. Amselem L, Diaz-Llopis M, Garcia-Delpech S, Montero J, Palomares P, Cervera E. Papulopustular eruption after intravitreal bevacizumab (Avastin). Acta Ophthalmol. 2009;87(1):110-111.
4. Agero AL, Dusza SW, Benvenuto-Andrade C, Busam KJ, Myskowski P, Halpern AC. Dermatological side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol. 2006;55(4):657-670. (Pubitemid 44436627)
5. Man XY, Yang XH, Cai SQ, et al. Expression and localization of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in human epidermal appendages: a comparison study by immunofluorescence. Clin Exp Dermatol. 2009;34(3):396-401.